Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Acetoacetic acid lithium salt (Lithium 3-Oxobutyrate) is a weak organic acid that can be produced in the human liver under certain conditions of poor Metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
10 mg | お問い合わせ | ¥ 7,000 |
50 mg | お問い合わせ | ¥ 11,500 |
200 mg | お問い合わせ | ¥ 15,500 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,500 |
説明 | Acetoacetic acid lithium salt (Lithium 3-Oxobutyrate) is a weak organic acid that can be produced in the human liver under certain conditions of poor Metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis). |
別名 | LithoTab acetoacetate, Lithium acetoacetate, Lithium 3-Oxobutyrate |
分子量 | 108.02 |
分子式 | C4H5LiO3 |
CAS No. | 3483-11-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 1.08 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Acetoacetic acid lithium salt 3483-11-2 Metabolism Others Endogenous Metabolite Acetoacetic acid LithoTab acetoacetate Lithium acetoacetate Lithium 3-Oxobutyrate Inhibitor inhibit Acetoacetic acid lithium Lithium Acetoacetate LithoTab Acetoacetate inhibitor